Key points are not available for this paper at this time.
O-GlcNAc glycosylation (or O-GlcNAcylation) is a dynamic, inducible posttranslational modification found on proteins associated with neurodegenerative diseases such as α-synuclein, amyloid precursor protein, and tau. Deletion of the O-GlcNAc transferase (ogt) gene responsible for the modification causes early postnatal lethality in mice, complicating efforts to study O-GlcNAcylation in mature neurons and to understand its roles in disease. Here, we report that forebrain-specific loss of OGT in adult mice leads to progressive neurodegeneration, including widespread neuronal cell death, neuroinflammation, increased production of hyperphosphorylated tau and amyloidogenic Aβ-peptides, and memory deficits. Furthermore, we show that human cortical brain tissue from Alzheimer's disease patients has significantly reduced levels of OGT protein expression compared with cortical tissue from control individuals. Together, these studies indicate that O-GlcNAcylation regulates pathways critical for the maintenance of neuronal health and suggest that dysfunctional O-GlcNAc signaling may be an important contributor to neurodegenerative diseases.
Building similarity graph...
Analyzing shared references across papers
Loading...
Andrew C. Wang
Johns Hopkins University
Elizabeth H. Jensen
California Institute of Technology
Jessica E. Rexach
University of California, Los Angeles
Proceedings of the National Academy of Sciences
University of California, Los Angeles
California Institute of Technology
Building similarity graph...
Analyzing shared references across papers
Loading...
Wang et al. (Mon,) studied this question.
synapsesocial.com/papers/69d6965a9b6ed6ae1a029dd9 — DOI: https://doi.org/10.1073/pnas.1606899113
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: